Quality by Design (QbD): Beyond Mere Compliance
Quality by Design (QbD) principles have been incorporated into regulatory guidelines for over two decades, so regulated life science companies are familiar with the requirements…
Quality by Design (QbD) principles have been incorporated into regulatory guidelines for over two decades, so regulated life science companies are familiar with the requirements…
Last year’s guidance from the FDA regarding human gene therapy products (Human Gene Therapy Products: Incorporating Human Genome Editing Guidance for Industry, FDA January 2024)…
Human Gene Therapy Products: Incorporating Human Genome Editing Guidance for Industry: Part 1 The FDA recently released guidance (FDA- Human Gene Therapy Products: Incorporating Human…
CPV is a method used in pharmaceutical manufacturing to ensure consistent product quality and regulatory compliance. It involves the continuous monitoring of critical process parameters…
CMC Due Diligence Best Practices Due diligence is crucial in the pharmaceutical industry for mitigating risks and ensuring success, especially during mergers, acquisitions, and licensing…
CMC Due Diligence Common Stumbling Blocks Conducting thorough CMC due diligence in the pharmaceutical industry is essential to avoid pitfalls that can jeopardize the success of…
Running afoul of the adage, “measure twice, cut once” can upend a construction project. But what it can do to a CMC (Chemistry, Manufacturing, and…
In this fast paced and dynamic life sciences industry, it’s worth remembering regulatory compliance is a journey, not a destination. It requires a proactive approach to adapt…
We are honored to share that Windshire's president, James Blackwell, PhD, MBA/MS will join Amnon Eylath as guest speakers for PDA New England They will present…
We are thrilled to announce that Windshire's esteemed President and Principal Consultant, Dr. James Blackwell, PhD, MBA/MS, will be attending the highly anticipated Bio International…